È®À强 ½É±ÙÁõ ȯÀÚ¿¡¼­ ½É½Çºó¸Æ
Ventricular tachycardia in patients with dilated cardiomyopathy

International Journal of Arrhythmia 2013³â 14±Ç 3È£ p.22 ~ p.25

±èÁø¼®(Kim Jin-Seok) - ¼¼Á¾º´¿ø ½ÉÀå³»°ú

Abstract

Dilated cardiomyopathy (DCM) is the most common cardiomyopathy characterized by left or biventricular dilatation and systolic dysfunction. Ventricular tachycardia (VT) may be an important cause of sudden death and morbidity in patients with DCM. Although advances in both drug and device therapy have led to an improvement in overall survival of patients with DCM, symptomatic VT and the risk of sudden death are still issues that must be considered. Recent advances in catheter ablation technolgy have led to an improved success rate, and they have facilitated the use of catheter ablation in VT related to DCM.

Å°¿öµå

ablation, dilated cardiomyopathy, implantable cardioverter defibrillator, ventricular tachycardia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Recent advances in catheter ablation technology have led to an improved success rate.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå